Malvern Institute

Stay Connected With Malvern. Get Email Updates

info@malverninstitute.com | Follow Us:

Health insurance provider to make Narcan free for members

February 21, 2018 – Giving communities the tools to help citizens struggling with the disease of addiction is vital in the battle to curb the nation’s drug epidemic. A local health insurance provider will now provide the life-saving antidote for opioid and heroin overdoses free of charge.

Independence Blue Cross, a Philadelphia-based company, will stop charging members for naloxone, a nasal spray that blocks the effects of opioids on the body. The state of Pennsylvania has made naloxone available without a prescription to help save lives.

The life-saving antidote was administered approximately 4,000 times by the Philadelphia Fire Department and 200 times by Philadelphia police in 2016, according to a report issued last May by the Mayor’s Task Force to Combat the Opioid Epidemic in Philadelphia.

“By removing a financial barrier to accessing naloxone, we can make the drug more readily available and hopefully save more lives,” said Dr. Richard Snyder, chief medical officer for Independence Blue Cross and a member of the Mayor’s Task Force. “Our hope is that anyone struggling with opioid addiction can get appropriate treatment, but they have to be alive to take that step.”

Malvern Institute: We Give Hope

If you or a loved one are living with addiction, we can help. Learn about Malvern Intervention Services or the Malvern Model Of Care by calling 610.MALVERN (610.625.8376).

Read more coverage from PhillyVoice.

Testimonials

Recent News

Podcast tackles science behind addiction treatment, opioid epidemic

March 30, 2018 – Raising awareness of the facts about the disease of addiction and breaking the stigma associated with addiction are necessary steps toward truly helping families affected by the disease of addiction. This month, Gimlet Media’s “Science Vs.” podcast released two episodes dedi...

Read More

See All News

© 2017 Malvern Institute - All Rights Reserved | View Privacy Policy